Preclinical study of the human recombinant Erythropoietin (GBPD002) compared with Eprex®
Kakon Nag,
Mohammad Mohiuddin,
Maksudur Rahman Khan
et al.
Abstract:Erythropoietin (EPO) is a glycoprotein that an essential growth factor for erythroid progenitors at the bone marrow, which appears in blood as a response to hypoxia. It is produced mainly by the kidneys; and its biosynthesis and release are stimulated by the reduction of tissue oxygenation and/or the reduction of the mass of erythrocytes. Here, we report the results of the preclinical evaluation of the safety of ‘GBPD002’ a recombinant human erythropoietin (rhEPO) developed by the Globe Biotech Limited, Bangla… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.